| LIQUIDIA CORP. DL-,001 |
| USA |
| Gesundheit |
| US53635D2027 / A2JRNS |
| LT4 (Frankfurt) / LQDA (NASDAQ) |
| FRA:LT4, ETR:LT4, LT4:GR, NASDAQ:LQDA |
| - |
| https://liquidia.com/ |
|
Liquidia Corporation is a biopharmaceutical compan..
>Volltext.. |
| 2374.86 Mio. EUR |
| 2410.46 Mio. EUR |
| 59.49 Mio. EUR |
| -90.72 Mio. EUR |
| -104.73 Mio. EUR |
| -1.23 EUR |
| 171.2 Mio. EUR |
| 135.37 Mio. EUR |
| -86.59 Mio. EUR |
| 1.53 |
| 320.72% |
| 3.23% |
| - |
| - |
| - |
| - |
| LIQUIDIA |
| 10.01.26 |